Demand for Galderma Shares Exceeds Available Supply

Reports suggest that the demand for shares at a price of 89 Swiss Francs exceeds the available supply. The expected forecast amounts to 1.34 billion Swiss Francs.


Demand for Galderma Shares Exceeds Available Supply

The conditions for the share purchase at the fixed price showed that the available requests exceeded several times and did not accept more than the requests. It is anticipated that a group of allocations will be determined, which includes "Abu Dhabi Investment Company", "Adia", "IKC" EQT AB, and "Oba Investment", at a selling price of approximately 15 million shares at around 89 Swiss francs per share.

Bloomberg accounts indicate that this price represents a discount of about 7.8% from the closing price of the shares on Monday. It is expected that subscriptions will gather approximately 1.34 billion Swiss francs (1.5 billion dollars) from the sale of shares amounting to about 6.3% in the Swiss parent company.

"The requests were much greater than expected, and only a few of the available shares remain," according to the available information.